Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROOF: Fosfomycin PK/PD in Healthy Adults
NCT02570074Phase 1Completed
- Start
- Jan 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fosfomycin in complicated urinary tract infection (cUTI) (2 arms). Primary endpoints: Number (%) of Grade 2 or Higher AEs Regardless of Relationship to Study Drug at 3 months, Plasma PK Concentrations at Day 5 and 3 more. Started Jan 2016; status: completed.
02
Drugs
fosfomycin
03
Conditions
complicated urinary tract infection (cUTI)
Beyond the preview
Go deeper on NCT02570074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02570074.